Healthtech Startups

Scancell is a late-stage clinical biotechnology company developing active immunotherapies to strengthen anti-tumor immune responses in hard-to-treat cancers. Its treatments are built on its proprietary Immunobody and Moditope platforms.

1 investor

Scanwell Health develops smartphone applications that enable patients to perform diagnostic tests at home, starting with an FDA-cleared app for urinary tract infection testing and treatment. The platform targets people seeking faster diagnosis and treatment of acute and chronic conditions without visiting a clinic.

1 investor

Scarlet Home Healthcare offers personal care aide services that assist clients with activities of daily living such as bathing and dressing, often coordinating with occupational therapy for adaptive equipment use.

1 investor

SCD Probiotics develops a fermentation-based biological platform that grows multiple microbial strains together into consortia to produce probiotics and microbial biochemicals. Its products serve applications ranging from gut and home health to industrial uses such as leather processing, offering bio-based, non-toxic alternatives to petroleum-based chemicals.

1 investor

Scene provides digital medication adherence programs combining video check-ins and human engagement by nurses and pharmacists to improve patient adherence and health outcomes across health systems and care organizations. The company evolved from emocha, a Johns Hopkins-originated technology that has expanded globally to address medication nonadherence in infectious disease treatment and other conditions.

1 investor

SchedulingWiz builds automated physician scheduling software for hospital departments and medical institutions. The platform creates resident, fellow, and attending schedules for specialties including neurology, emergency medicine, and surgery.

1 investor

An international non-profit organisation (operating as Unlimit Health, formerly the Schistosomiasis Control Initiative) that works with affected countries to treat and eliminate parasitic diseases such as schistosomiasis and soil-transmitted helminthiasis. It supports health systems with evidence, data, and partnerships to deliver mass treatment programmes and disease elimination.

1 investor

Schivo is a contract manufacturer specializing in medical device components, sub-assemblies, and assemblies for minimally invasive, robotic-assisted, cardiology, and orthopedic surgery systems. The company serves original equipment manufacturers (OEMs) in the medical device industry through ISO 13485-certified and FDA-registered facilities across multiple continents.

1 investor

Schoolbeat provides a platform that helps school districts align student wellness, character skills, and school climate initiatives with available federal, state, and local funding opportunities. The platform enables universal instruction, targeted supports, and individualized interventions while tracking competencies and outcomes across multi-tiered systems of support.

1 investor

Dr. Willmar Schwabe is a family-owned pharmaceutical company that researches, develops, and manufactures herbal medicines (phytopharmaceuticals) derived from plants, controlling the full production process from planting to packaging. Its products are sold through pharmacies and manufactured in Germany.

1 investor

Science Care operates a non-transplant tissue banking program that partners with medical researchers and educators, enabling donor contributions for medical research, education, and product development. Founded in 2000, the organization manages donation programs while prioritizing donor dignity, ethical practices, and industry standards.

1 investor

Scilife builds an electronic quality management system for regulated industries such as healthcare and life sciences, helping teams automate compliance workflows and advance quality operations beyond minimum standards.

1 investor

SciLifeLab is a Swedish national research infrastructure organization that provides advanced technologies, expertise, and support services to life science researchers across Swedish universities. The organization operates ten national platforms offering various technologies and services through specialized units.

1 investor

Scinvivo develops Lumante, a catheter-based optical coherence tomography (OCT) imaging platform for real-time, minimally invasive visualization and local staging of bladder cancer during cystoscopy. The system, aimed at urologists, has received FDA Breakthrough Device Designation and is in pre-clinical/clinical development.

1 investor

SciSafe provides biopharmaceutical storage, sample management, and cold chain logistics services for pharmaceutical companies, research institutes, and biotech firms across regulated temperature-controlled facilities. The company operates internationally with locations in New Jersey, Massachusetts, and the Netherlands, maintaining FDA, EU GDP, ISO, and CAP certifications.

1 investor

Sciteline provides digital recruitment technology for clinical research trials, helping researchers access diverse patient populations and accelerate trial enrollment. The platform aims to expand patient access to clinical studies and improve healthcare inclusivity through data-driven matching tools.

1 investor

Scitherm uses enzymatic synthesis to create novel structural variants with thermogenic activity, validated through channel affinity, in-vitro lipolysis, and in-vivo fat mass reduction studies. The company develops science-based thermal solutions aimed at metabolic health.

1 investor

Sciwind Biosciences is a commercial-stage biopharmaceutical company that discovers, develops, and delivers therapeutics focused on metabolic and weight management conditions, serving patients globally. It advances internal R&D programs and pursues out-licensing partnerships to bring treatments to market.

1 investor

SC Labs and ACT Laboratories jointly operate a certification initiative that establishes rigorous lab quality standards for cannabis testing to ensure accuracy, integrity, and transparency. The program helps brands demonstrate commitment to quality through a Trust logo while enabling consumers to identify safer products.

1 investor

Aitrasound Medical Group develops and markets radiation-free ultrasound equipment for scoliosis assessment, serving hospitals and clinics globally. The company's Scolioscan system uses 3D imaging technology and has been deployed across Europe, Australia, and Asia.

1 investor

Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.

1 investor

Scope Impact designs and scales climate-resilient, community-based health solutions through evidence-based, people-centric interventions that combine scientific research with lived experience. The organization serves health systems and communities globally, with a focus on advancing universal health coverage and health equity in the face of climate change.

1 investor

ScopeSys develops single-molecule imaging technology, called Convex Lens-induced Confinement (CLiC), that enables high-throughput measurements with single-molecule resolution for genomic-medicine drug development. Its platform helps developers of RNA, DNA, and nanoparticle-delivered drugs analyze single-molecule interactions to optimize therapeutic sequences and mRNA lipid nanoparticle formulations.

1 investor

Score Pharma is a biotech company developing biosuperior antibody therapeutics aimed at cancer treatment.

1 investor